NFKB1 and B-cell chronic lymphocytic leukemia: Some studies have demonstrated that APRIL, as an oncogene, upregulated in non-canonical NF-kB signaling pathway and that dysregulation of this signaling pathway contributes to development and evolution of B-CLL (Van Attekum et al., 2016).